Taxol Patents Reveal Bristol Strategy to Safeguard Market Against Competitors
In Brief: HHS Names Deputy HCFA Administrator; M.D. Anderson’s Error-Free Record Honored
FDA News: ODAC Recommends Taxol For KS; Votes Against 2 Other Drugs
Cancer Prevention; BCPT Enrollment Final At 13,000 After 5 Years
Receipt Dates Clarified For AIDS-Cancers PA
Letter; ASSIST Prevents Cancer, Should Remain in NCI Portfolio
Grants Funding; NCI Restores Paylines To Last Year’s Levels
AHCPR Funds Centers to Review Practice
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- Anthony Letai pledges to ensure stability for extramural and intramural cancer science
- Vinay Prasad to CBER employees: “It is not wise for FDA to further pollute the scientific literature with papers we cannot defend”









